バーチャルバイオプシーの世界市場レポート 2025年

バーチャルバイオプシー市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は12.0％で、11億2,000万米ドルに成長します。予測期間中に期待される成長は、費用対効果の高いヘルスケアソリューションへの注目の高まり、予防医療の重視、個別化医療への需要の高まり、低侵襲がん治療への関心の高まり、プレシジョン・オンコロジーの重要性の高まりなどの要因によってもたらされます。予測期間における主な動向としては、高度な画像センサーの開発、マルチモーダル生検技術の進化、ロボット工学との統合による精度向上、非侵襲的バイオマーカー検出の革新、3次元（3D）可視化ツールの導入などが挙げられます。

腫瘍性疾患の有病率の増加は、今後数年間のバーチャルバイオプシー市場の成長を大きく促進すると予想されます。腫瘍学的疾患とは、体内の細胞の異常増殖や拡散を特徴とするがん関連の健康状態を指します。このようながん患者の増加は、食生活の乱れ、運動不足、タバコの消費、環境汚染物質へのさらなる暴露などのライフスタイル要因に大きく起因しています。バーチャルバイオプシーは、診断精度と患者の安全性を高めながら、従来の組織生検の必要性を最小限にする非侵襲的なリアルタイムイメージングソリューションを提供することで、これらの疾患の診断とモニタリングをサポートします。例えば、2024年7月、オーストラリア保健福祉研究所は、オーストラリアにおけるがん診断件数が2021年の15万6,781件から2022年には16万570件に増加し、3,789件増加したと報告しました。その結果、腫瘍性疾患の罹患率の増加がバーチャルバイオプシー市場の拡大に拍車をかけています。

バーチャルバイオプシー市場の主なプレーヤーは、非侵襲的診断の精度を向上させ、疾患の早期発見と個別化医療をサポートするために、磁気共鳴分光法（MRS）プラットフォームなどの先進技術の開発と規制当局の承認を優先しています。MRSは、組織の詳細な分子情報を提供することでバーチャルバイオプシーを支援する非侵襲的イメージング法であり、リアルタイムの疾患モニタリングを可能にし、外科的処置の必要性を排除します。例えば、2023年11月、米国のヘルステック企業であるBrainSpec Inc.は、AIを搭載したBrainSpecプラットフォームについて米国食品医薬品局（FDA）から承認を受けた。このプラットフォームは、人工知能を用いてMRスペクトロスコピーデータを解析し、2-ヒドロキシグルタル酸などの脳代謝物を検出するもので、神経膠腫、アルツハイマー病、多発性硬化症の診断のための非侵襲的仮想生検を可能にします。このシステムは標準的なMRIスキャナーと統合され、データ解析を自動化し、数分以内に結果を提供し、診断の信頼性を向上させるために脳化学の参照データベースに依存しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バーチャルバイオプシーPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバーチャルバイオプシー市場：成長率分析
• 世界のバーチャルバイオプシー市場の実績：規模と成長, 2019-2024
• 世界のバーチャルバイオプシー市場の予測：規模と成長, 2024-2029, 2034F
• 世界バーチャルバイオプシー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバーチャルバイオプシー市場対象治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍性疾患
• 神経疾患
• 心血管疾患
• 眼科疾患
• 内分泌疾患
• 胃腸障害
• その他のターゲット治療領域
• 世界のバーチャルバイオプシー市場がんをターゲットにした、実績と予測, 2019-2024, 2024-2029F, 2034F
• 固形悪性腫瘍
• 乳がん
• 肺がん
• 前立腺がん
• 大腸がん
• 脳腫瘍
• その他のがん標的
• 世界のバーチャルバイオプシー市場イメージングテクノロジーズ、実績と予測, 2019-2024, 2024-2029F, 2034F
• 磁気共鳴画像法
• コンピュータ断層撮影
• X線
• 超音波
• その他の画像技術
• 世界のバーチャルバイオプシー市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 調査機関および診断センター
• その他のエンドユーザー
• 世界のバーチャルバイオプシー市場腫瘍性疾患の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肺がん
• 乳がん
• 前立腺がん
• 大腸がん
• 肝臓がん
• 脳腫瘍
• その他のがん
• 世界のバーチャルバイオプシー市場神経疾患の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルツハイマー病
• パーキンソン病
• 多発性硬化症
• てんかん
• 脳損傷
• 脳卒中
• その他の神経疾患
• 世界のバーチャルバイオプシー市場、心血管疾患の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 冠動脈疾患
• 心不全
• 不整脈
• 大動脈瘤
• 心臓弁膜症
• 心筋梗塞
• その他の心血管疾患
• 世界のバーチャルバイオプシー市場眼科疾患の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 加齢黄斑変性症
• 糖尿病網膜症
• 緑内障
• 網膜静脈閉塞症
• 白内障
• その他の眼疾患
• 世界のバーチャルバイオプシー市場内分泌疾患の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 糖尿病
• 甲状腺疾患
• 副腎疾患
• 下垂体疾患
• 副甲状腺疾患
• その他の内分泌疾患
• 世界のバーチャルバイオプシー市場消化器疾患の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 炎症性腸疾患
• 大腸ポリープ
• 胃潰瘍
• 肝硬変
• 膵臓疾患
• 肝炎
• その他の胃腸疾患
• 世界のバーチャルバイオプシー市場その他のターゲット治療領域のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 筋骨格系障害
• 腎疾患
• 肺疾患
• 血液疾患
• 皮膚疾患
• 感染症
• その他の諸条件

第7章 地域別・国別分析

• 世界のバーチャルバイオプシー市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバーチャルバイオプシー市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バーチャルバイオプシー市場：競合情勢
• バーチャルバイオプシー市場：企業プロファイル
  • Canon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Hologic Inc.
• Illumina Inc.
• Guardant Health Inc.
• Esaote S.p.A
• Samsung Medison Co Ltd.
• Telix Pharmaceuticals Limited
• Freenome Holdings Inc.
• Perspectum Ltd.
• QUIBIM S.L
• IQ-AI Limited
• BrainSpec Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バーチャルバイオプシー市場2029：新たな機会を提供する国
• バーチャルバイオプシー市場2029：新たな機会を提供するセグメント
• バーチャルバイオプシー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Virtual biopsy is a non-invasive diagnostic method that leverages advanced imaging technologies and computer algorithms to analyze tissues for signs of disease. Its primary goal is to identify abnormalities, such as tumors or infections, without the need for traditional tissue sampling, minimizing risks and recovery time for patients. This technique is safer, faster, and less painful compared to conventional biopsies.

The main therapeutic areas targeted by virtual biopsy include oncology, neurology, cardiology, ophthalmology, endocrinology, gastroenterology, and other related conditions. Oncological disorders involve diseases characterized by the uncontrolled growth and spread of abnormal cells, commonly known as cancer, which can affect various organs and tissues. Virtual biopsy is used for detecting a wide range of cancers, including solid tumors, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer, and others. The imaging technologies utilized in virtual biopsy include magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, among others, and are employed by end users such as hospitals, clinics, research institutes, diagnostic centers, and more.

The virtual biopsy market research report is one of a series of new reports from The Business Research Company that provides virtual biopsy market statistics, including the virtual biopsy industry's global market size, regional shares, competitors with the virtual biopsy market share, detailed virtual biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the virtual biopsy market. This virtual biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The virtual biopsy market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.71 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth observed during the historic period can be attributed to the increasing demand for non-invasive diagnostic techniques, a growing preference for early disease detection, enhanced efficiency in medical imaging software, greater patient convenience and comfort, and the expanding availability of telemedicine services.

The virtual biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.12 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The expected growth in the forecast period is driven by factors such as a greater focus on cost-effective healthcare solutions, an emphasis on preventive healthcare, increasing demand for personalized medicine, rising interest in minimally invasive cancer treatments, and the growing significance of precision oncology. Key trends in the forecast period include the development of advanced imaging sensors, the evolution of multimodal biopsy techniques, integration with robotics for enhanced precision, innovations in non-invasive biomarker detection, and the incorporation of three-dimensional (3D) visualization tools.

The increasing prevalence of oncological disorders is anticipated to significantly drive the growth of the virtual biopsy market in the coming years. Oncological disorders refer to cancer-related health conditions characterized by the abnormal growth and spread of cells within the body. This rise in cancer cases is largely attributed to lifestyle factors such as poor dietary habits, physical inactivity, tobacco consumption, and greater exposure to environmental pollutants. Virtual biopsy supports the diagnosis and monitoring of these disorders by offering non-invasive, real-time imaging solutions that minimize the need for traditional tissue biopsies while enhancing diagnostic precision and patient safety. For example, in July 2024, the Australian Institute of Health and Welfare reported that cancer diagnoses in Australia increased to 160,570 in 2022, up from 156,781 in 2021-an increase of 3,789 cases. As a result, the growing incidence of oncological disorders is fueling the expansion of the virtual biopsy market.

Key players in the virtual biopsy market are prioritizing the development of advanced technologies and regulatory approvals, such as magnetic resonance spectroscopy (MRS) platforms, to improve the accuracy of non-invasive diagnostics and support early disease detection and personalized care. MRS is a non-invasive imaging method that assists virtual biopsy by delivering detailed molecular information of tissues, enabling real-time disease monitoring and eliminating the need for surgical procedures. For instance, in November 2023, BrainSpec Inc., a U.S.-based healthtech company, received approval from the U.S. Food and Drug Administration (FDA) for its AI-powered BrainSpec platform. This platform analyzes MR spectroscopy data using artificial intelligence to detect brain metabolites such as 2-hydroxyglutarate, enabling non-invasive virtual biopsies for diagnosing gliomas, Alzheimer's disease, and multiple sclerosis. The system integrates with standard MRI scanners, automates data analysis, delivers results within minutes, and relies on a reference database of brain chemistry to improve diagnostic reliability.

In July 2022, Quibim S.L., a healthtech firm based in Spain, entered a partnership with Microsoft Corporation to develop artificial intelligence-powered virtual biopsy tools. This collaboration seeks to advance non-invasive diagnostic capabilities by merging Quibim's AI-based imaging solutions with Microsoft's Azure cloud infrastructure. The goal is to enhance disease detection accuracy and minimize dependence on conventional biopsy techniques. Microsoft Corporation, headquartered in the U.S., is a globally recognized technology company known for its software products and digital services.

Major players in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co. Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc., ImageBiopsy Lab GmbH, AI Metrics LLC, and Deep Bio Inc.

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in virtual biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the virtual biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The virtual biopsy market consists of revenues earned by entities by providing services such as imaging diagnostics, artificial intelligence (AI)-based interpretation, biomarker testing, telemedicine services, and three-dimensional (3D) tissue modeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The virtual biopsy market also includes sales of biopsy needle systems, artificial intelligence (AI)-based diagnostic tools, endoscopic systems, and photoacoustic imaging devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Virtual Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on virtual biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for virtual biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The virtual biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Target Thrapeutic Areas: Oncological Disorders; Neurological Disorders; Cardiovascular Disorders; Ophthalmological Disorders; Endocrine Disorders; Gastrointestinal Disorders; Other Target Therapeutic Areas
• 2) By Cancer Targeted: Solid Malignancies; Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Cancer; Other Cancer Targeteds
• 3) By Imaging Technologies: Magnetic Resonance Imaging; Computed Tomography; X-Ray; Ultrasound; Other Imaging Technologies
• 4) By End Users: Hospitals And Clinics; Research Institutes And Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Oncological Disorders: Lung Cancer; Breast Cancer; Prostate Cancer; Colorectal Cancer; Liver Cancer; Brain Tumors; Other Cancers
• 2) By Neurological Disorders: Alzheimer's Disease; Parkinson's Disease; Multiple Sclerosis; Epilepsy; Brain Injuries; Stroke; Other Neurological Conditions
• 3) By Cardiovascular Disorders: Coronary Artery Disease; Heart Failure; Arrhythmias; Aortic Aneurysm; Valvular Heart Disease; Myocardial Infarction; Other Cardiovascular Conditions
• 4) By Ophthalmological Disorders: Age-Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Retinal Vein Occlusion; Cataracts; Other Eye Disorders
• 5) By Endocrine Disorders: Diabetes Mellitus; Thyroid Disorders; Adrenal Gland Disorders; Pituitary Gland Disorders; Parathyroid Disorders; Other Endocrine Conditions
• 6) By Gastrointestinal Disorders: Inflammatory Bowel Disease; Colorectal Polyps; Gastric Ulcers; Liver Cirrhosis; Pancreatic Disorders; Hepatitis; Other Gastrointestinal Conditions
• 7) By Other Target Therapeutic Areas: Musculoskeletal Disorders; Renal Disorders; Pulmonary Disorders; Hematologic Disorders; Dermatological Disorders; Infectious Diseases; Other Miscellaneous Conditions
• Companies Mentioned: Canon Inc.; Siemens Healthineers AG; GE Healthcare; Quest Diagnostics Incorporated; Olympus Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Virtual Biopsy Market Characteristics

3. Virtual Biopsy Market Trends And Strategies

4. Virtual Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Virtual Biopsy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Virtual Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Virtual Biopsy Market Growth Rate Analysis
• 5.4. Global Virtual Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Virtual Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Virtual Biopsy Total Addressable Market (TAM)

6. Virtual Biopsy Market Segmentation

• 6.1. Global Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncological Disorders
• Neurological Disorders
• Cardiovascular Disorders
• Ophthalmological Disorders
• Endocrine Disorders
• Gastrointestinal Disorders
• Other Target Therapeutic Areas
• 6.2. Global Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Malignancies
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Cancer
• Other Cancer Targeteds
• 6.3. Global Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetic Resonance Imaging
• Computed Tomography
• X-Ray
• Ultrasound
• Other Imaging Technologies
• 6.4. Global Virtual Biopsy Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research Institutes And Diagnostic Centers
• Other End Users
• 6.5. Global Virtual Biopsy Market, Sub-Segmentation Of Oncological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Liver Cancer
• Brain Tumors
• Other Cancers
• 6.6. Global Virtual Biopsy Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Epilepsy
• Brain Injuries
• Stroke
• Other Neurological Conditions
• 6.7. Global Virtual Biopsy Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coronary Artery Disease
• Heart Failure
• Arrhythmias
• Aortic Aneurysm
• Valvular Heart Disease
• Myocardial Infarction
• Other Cardiovascular Conditions
• 6.8. Global Virtual Biopsy Market, Sub-Segmentation Of Ophthalmological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Age-Related Macular Degeneration
• Diabetic Retinopathy
• Glaucoma
• Retinal Vein Occlusion
• Cataracts
• Other Eye Disorders
• 6.9. Global Virtual Biopsy Market, Sub-Segmentation Of Endocrine Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diabetes Mellitus
• Thyroid Disorders
• Adrenal Gland Disorders
• Pituitary Gland Disorders
• Parathyroid Disorders
• Other Endocrine Conditions
• 6.10. Global Virtual Biopsy Market, Sub-Segmentation Of Gastrointestinal Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Bowel Disease
• Colorectal Polyps
• Gastric Ulcers
• Liver Cirrhosis
• Pancreatic Disorders
• Hepatitis
• Other Gastrointestinal Conditions
• 6.11. Global Virtual Biopsy Market, Sub-Segmentation Of Other Target Therapeutic Areas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Musculoskeletal Disorders
• Renal Disorders
• Pulmonary Disorders
• Hematologic Disorders
• Dermatological Disorders
• Infectious Diseases
• Other Miscellaneous Conditions

7. Virtual Biopsy Market Regional And Country Analysis

• 7.1. Global Virtual Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Virtual Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Virtual Biopsy Market

• 8.1. Asia-Pacific Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Virtual Biopsy Market

• 9.1. China Virtual Biopsy Market Overview
• 9.2. China Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Virtual Biopsy Market

• 10.1. India Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Virtual Biopsy Market

• 11.1. Japan Virtual Biopsy Market Overview
• 11.2. Japan Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Virtual Biopsy Market

• 12.1. Australia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Virtual Biopsy Market

• 13.1. Indonesia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Virtual Biopsy Market

• 14.1. South Korea Virtual Biopsy Market Overview
• 14.2. South Korea Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Virtual Biopsy Market

• 15.1. Western Europe Virtual Biopsy Market Overview
• 15.2. Western Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Virtual Biopsy Market

• 16.1. UK Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Virtual Biopsy Market

• 17.1. Germany Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Virtual Biopsy Market

• 18.1. France Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Virtual Biopsy Market

• 19.1. Italy Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Virtual Biopsy Market

• 20.1. Spain Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Virtual Biopsy Market

• 21.1. Eastern Europe Virtual Biopsy Market Overview
• 21.2. Eastern Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Virtual Biopsy Market

• 22.1. Russia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Virtual Biopsy Market

• 23.1. North America Virtual Biopsy Market Overview
• 23.2. North America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Virtual Biopsy Market

• 24.1. USA Virtual Biopsy Market Overview
• 24.2. USA Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Virtual Biopsy Market

• 25.1. Canada Virtual Biopsy Market Overview
• 25.2. Canada Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Virtual Biopsy Market

• 26.1. South America Virtual Biopsy Market Overview
• 26.2. South America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Virtual Biopsy Market

• 27.1. Brazil Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Virtual Biopsy Market

• 28.1. Middle East Virtual Biopsy Market Overview
• 28.2. Middle East Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Virtual Biopsy Market

• 29.1. Africa Virtual Biopsy Market Overview
• 29.2. Africa Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Virtual Biopsy Market Competitive Landscape And Company Profiles

• 30.1. Virtual Biopsy Market Competitive Landscape
• 30.2. Virtual Biopsy Market Company Profiles
  • 30.2.1. Canon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Virtual Biopsy Market Other Major And Innovative Companies

• 31.1. Hologic Inc.
• 31.2. Illumina Inc.
• 31.3. Guardant Health Inc.
• 31.4. Esaote S.p.A
• 31.5. Samsung Medison Co Ltd.
• 31.6. Telix Pharmaceuticals Limited
• 31.7. Freenome Holdings Inc.
• 31.8. Perspectum Ltd.
• 31.9. QUIBIM S.L
• 31.10. IQ-AI Limited
• 31.11. BrainSpec Inc.

32. Global Virtual Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Virtual Biopsy Market

34. Recent Developments In The Virtual Biopsy Market

35. Virtual Biopsy Market High Potential Countries, Segments and Strategies

• 35.1 Virtual Biopsy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Virtual Biopsy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Virtual Biopsy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer